ReviewDiabetes, obesity & metabolism2018

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.

Serge Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.